Source: MarketWatch ↗
Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
|
Translation unavailable. Please try again.
What the source reports
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
Read the original report on MarketWatch ↗